Nutraceuticals CDMO Market Outlook and Forecast
The Nutraceuticals CDMO Market continues to evolve as dietary supplement manufacturers increasingly rely on contract development and manufacturing organizations (CDMOs) to accelerate innovation, optimize production efficiency, and ensure regulatory compliance. Growing consumer awareness regarding preventive healthcare, personalized nutrition, and functional food products has created strong demand for specialized manufacturing partners capable of delivering high-quality nutraceutical formulations across multiple dosage forms. CDMOs are strengthening their capabilities through advanced manufacturing technologies, quality assurance systems, and flexible production capacities to serve global brands and emerging companies alike.
2025 Market Size: USD 45.21 Billion
Projected 2035 Market Size: USD 94.93 Billion
Growth Forecast (2026–2035): 7.7%
Regional Performance Highlights
North America: North America remains a prominent market driven by rising consumer spending on dietary supplements, stringent quality standards, and the presence of leading nutraceutical manufacturers. CDMOs continue investing in automation, clean-label production, and specialized formulation capabilities to support innovative product launches.
Europe: Europe demonstrates steady expansion supported by regulatory emphasis on product quality, increasing demand for plant-based nutraceuticals, and strong research activities. Manufacturers are focusing on sustainable sourcing and premium ingredient processing to address changing consumer preferences.
Asia Pacific: Asia Pacific is emerging as a key manufacturing hub due to cost-effective production, expanding healthcare awareness, and growing exports of nutraceutical ingredients. Countries across the region continue to attract investments in modern manufacturing facilities and advanced packaging infrastructure.
Market Segment Analysis
Segment 1 – Manufacturing and Packaging: The Manufacturing and Packaging segment held the leading position in 2025 with a 33.92% market share. Increasing outsourcing of end-to-end production, filling, labeling, and packaging services enables nutraceutical brands to reduce operational complexity while maintaining quality and scalability.
Segment 2 – Tablets & Capsules: Tablets & Capsules accounted for the largest share of the nutraceuticals CDMO market dosage form segment in 2025. Their popularity is driven by convenience, dosage accuracy, longer shelf life, and broad consumer acceptance across vitamins, minerals, probiotics, herbal supplements, and functional ingredients.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/14915
Top Market Trends Transforming the Nutraceuticals CDMO Market
1. Rising Demand for Personalized Nutrition Solutions
Personalized nutrition is becoming a major growth driver for the nutraceuticals CDMO market. Consumers increasingly seek customized dietary supplements tailored to age, lifestyle, health conditions, and nutritional deficiencies. CDMOs are responding by offering flexible manufacturing processes capable of producing small batches, customized formulations, and innovative ingredient combinations while maintaining consistent quality standards.
2. Expansion of Clean-Label and Plant-Based Nutraceutical Products
Growing consumer preference for natural, organic, and plant-derived ingredients is encouraging manufacturers to develop clean-label nutraceutical products. CDMOs are expanding their ingredient sourcing capabilities, enhancing traceability systems, and investing in sustainable manufacturing practices to support brands seeking transparent and environmentally responsible production.
3. Digital Manufacturing and Smart Production Technologies
Advanced manufacturing technologies, including automation, digital quality monitoring, artificial intelligence, and predictive maintenance, are improving operational efficiency across nutraceutical manufacturing facilities. These innovations enable CDMOs to reduce production errors, improve consistency, optimize supply chains, and accelerate commercial-scale manufacturing.
4. Increasing Investment in Innovative Delivery Formats
Manufacturers continue diversifying beyond traditional tablets and capsules by introducing gummies, powders, stick packs, soft gels, chewables, and liquid formulations. CDMOs are investing in specialized production lines that accommodate multiple dosage forms while meeting evolving consumer preferences for convenience, taste, and product differentiation.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/14915
Recent Company Developments
- Lonza Group continued expanding its health and nutrition manufacturing capabilities through investments in advanced production technologies and capacity improvements to support increasing global demand for nutraceutical manufacturing services.
- Sirio Pharma strengthened its international presence by expanding gummy and soft gel manufacturing capabilities, enabling customers to commercialize innovative dietary supplement products across multiple markets.
- Catalent enhanced its consumer health manufacturing portfolio by investing in advanced dosage technologies and flexible production infrastructure supporting nutraceutical brands seeking scalable outsourcing solutions.
- Procaps Group focused on expanding its softgel manufacturing operations while introducing new formulation capabilities designed to improve bioavailability and product differentiation.
- NutraScience Labs expanded contract manufacturing services with additional formulation development and packaging capabilities to meet increasing demand from emerging nutraceutical brands.
- Vitaquest International invested in manufacturing modernization and quality management systems to support innovative dietary supplement formulations and enhanced production efficiency.
- Robinson Pharma continued expanding production capacity for tablets, capsules, powders, and gummies while strengthening compliance with international quality standards.
- Gummi World increased investments in gummy supplement manufacturing technologies, supporting growing demand for functional gummies across vitamins, minerals, and botanical formulations.
- SMP Nutra expanded formulation and private-label manufacturing services with greater emphasis on customized nutraceutical products, rapid product development, and flexible production capabilities.
- Aenova Group strengthened its contract manufacturing portfolio by enhancing pharmaceutical-grade manufacturing expertise applicable to premium nutraceutical production.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/14915
Related Reports
About Fundamental Business Insights:
Fundamental Business Insights is global market research and consulting company which is engaged in providing in depth market reports to its various types of clients like industrial sectors, financial sectors, universities, non-profit, and corporations. Our goal is to offer the correct information to the right stakeholder at the right time, in a format that enables logical and informed decision making. We have a team of consultants who have experience in offering executive level blueprints of markets and solutions. Our services include syndicated market studies, customized research reports, and consultation.
Contact us:
Robbin Fernandez
Head of Business Development
Fundamental Business Insights and Consulting
Email: sales@fundamentalbusinessinsights.com
